• AAO 2019’s government-affairs sessions are essential to your advocacy. Plan to attend each of these unparalleled opportunities that will help you best understand the federal policies and regulations that inform our advocacy and impact your practice every day. 

    SPE32 - Real World Evidence in Ophthalmology

    Saturday, Oct. 12, 12:15-1:45 p.m.
    Moscone Center, South 312-313
    Topic: Electronic Health Records, Information Technology
    Presenters: Michael X. Repka, MD, MBA, Malvina Eydelman, MD, Mark Blumenkranz, MD

    SPE38 - Giving a Voice to Your Patients: Best Practices for Grassroots Advocacy in Your Local Community

    Grassroots advocacy is putting to practice your perspective on patient care to help ensure our government’s laws and policies support ophthalmologists’ ability to protect sight. This training session will provide attendees with best practices for advocating at home and nationally to elected officials. This is a hands-on skills-building experience that covers all aspects of the Academy’s advocacy efforts.

    Saturday, Oct. 12, 3-4 p.m.
    Moscone Center, South 204
    Topic: Advocacy
    Presenters: Matt Daigle, Natasha L. Herz, MD, Jeff S. Maltzman, MD, John D. Peters, MD, Paul O. Phelps, MD, Nathan L. Scott, MD, Megan Tweed, MPP, Desta Wallace

    SPE46 - 2019 Medicare Update Forum

    The year 2020 marks the fourth for the Merit-Based Incentive Payment System (MIPS), and CMS is looking to streamline requirements and reduce administrative burden moving forward. Come hear about what will be new for MIPS, as well as other coding and reimbursement changes that will impact you and your practice next year. Meet the Academy experts who will be available to answer your questions at this informative session.

    Sunday, Oct. 13, 12:15-1:45 p.m.
    Moscone Center, West 3014
    Topic: Health Policy
    Presenters: Michael X. Repka, MD, MBA, David B. Glasser, MD, Cherie McNett, Jessica Peterson, MD, MPH

    SPE50 - Q&A With the FDA

    Have questions about the Food and Drug Administration drug or medical device approval process? Want to talk about new FDA initiatives? Need answers about the latest news affecting ophthalmic drugs and devices? Join FDA ophthalmic drug and device experts for a session providing the latest on agency initiatives and an open Q&A with the audience.

    Sunday, Oct. 13, 12:45-1:45 p.m.
    Moscone Center, South 312-313
    Topic: General Nonmedical
    Presenter: James Chodosh MD, MPH

    SYM20 - The Impact of AI on Ophthalmology

    Co-sponsored by the Committee on Medical Information Technology (CMIT)

    A rapid increase in computing power has converged with the accumulation of large piles of digital clinical data to produce what are already groundbreaking improvements in the way computers assist clinicians with the interpretation of clinical data. In ophthalmology, this innovation in artificial intelligence (AI) has come in the form of algorithms that can now help diagnose and stage some of our more common eye diseases. Learn about the technology that has made these advances possible and about what changes may be in store for the practice of ophthalmology. Specific areas to be addressed include ROP, telemedicine, retinal disease, glaucoma and the impact of this technology on the practice of ophthalmology.

    Sunday, Oct 13, 12:45-1:45 p.m.
    Moscone Center, South 152
    Topic: Electronic Health Records, Information Technology
    Presenters: Michael V. Boland, MD, PhD, Michele C. Lim, MD, John Campbell, MD, MPH, Robert Chang, MD, Aaron Lee, MD

    SPE57 - Stars in Their Eyes: How Astronauts’ Vision Is Impacted by Space Travel and Its Application to Ophthalmology Knowledge

    Interesting, novel, physiologic and pathologic neuro-ocular findings have been documented in astronauts during and after long-duration space flight; these have been termed "space flight-associated neuro-ocular syndrome" (SANS). The National Aeronautics and Space Administration (NASA) has documented clinical, ultrasound, optical coherence tomography imaging, and radiographic findings of SANS, including optic disc edema, globe flattening and nerve fiber layer infarcts. Panelists will discuss the latest research on SANS as our nation prepares for future manned missions to space and the impact of their findings on our understanding of other ocular conditions, such as glaucoma. A Q&A period will follow.

    Monday, Oct. 14, 12:45-1:45 p.m.
    Moscone Center, South 308
    Topic: Neuro-Ophthalmology
    Presenters: Andrew G. Lee, MD, Glenn Cockerham, MD (moderator)

    SYM30 - The Evolution and Effect of Genomic Medicine, Blockchain and Robot-assisted Surgery on the Practice of Ophthalmology

    Co-sponsored by the American Medical Association Ophthalmology Section Council

    Chair: Kevin Thomas Flaherty, MD

    Monday, Oct. 14, 8:30-10 a.m.
    Moscone Center, West 3020
    Topic: Health Policy
    Target Audience: Comprehensive & Subspecialist


    Blockchain Technology and Big Data - Robert T. Chang, MD

    Eye Robotic Surgery - Jean-Pierre Hubschman, MD

    Parker Heath Lecture: Precision Medicine, Health Economics and Practice Patterns - Barbara L. McAneny, MD